Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bamberg
Clinical trial register · Germany

Clinical Trials in Bamberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
Berlin 118 Essen 60 Hamburg 55 Dresden 53 Cologne 49

Trials with a site in Bamberg

7 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Bad Oldesloe, Bamberg, Berlin, Bielefeld, Bochum, Bremen, Chemnitz, Cologne
2026-08-24
Recruiting
AstraZeneca
Observational
125
Altenburg, Bad Bramstedt, Bamberg, Berlin, Braunschweig, Chemnitz, Erlangen, Hanover
2026-03-19
Recruiting
AstraZeneca
Phase 3
11,300
Aachen, Amberg, Bad Homburg, Bad Oeynhausen, Bamberg, Bechhofen, Berlin, Bochum
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Bad Homburg, Bamberg, Berlin, Bochum, Brandenburg an der Havel, Dresden, Essen, Friedrichsthal
2025-03-03
Active, closed
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
NCT06336330Heart Diseases, Cardiovascular Diseases, Heart Failure
AstraZeneca
Observational
831
Aachen, Alsfeld, Bamberg, Bechhofen, Bergisch Gladbach, Berlin, Brilon, Bruchsal
2024-04-25
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Active, closed
AstraZeneca
Phase 3
140
Bamberg, Freiburg im Breisgau, Hamburg, Kirchheim, Lübeck
2019-10-29
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-germany/city/bamberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Bamberg that also match the filters currently applied.

How many clinical trials are recruiting in Bamberg?

5 of the 7 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bamberg), 7 studies
PhaseStudiesRecruitingShare
Phase 35471.4%
Observational2128.6%

Most active sponsors

Lead sponsors with the most studies (Bamberg)
Lead sponsorStudiesRecruiting
AstraZeneca75
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.